A novel management program for hypertension.
Chunsong Hu(Nanchang University), Dayi Hu(Beihang University), Changsheng Ma(Second Hospital of Shandong University), Junbo Ge(Sun Yat-sen University), Tengiz Tkebuchava(Boston University), Qinghua Wu(Nanchang University), Yaling Han(Harbin Medical University), Yanna Liu(Linyi University)
Cited by 12
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
|Journal of Clinical Investigation|2003|262
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
|Cardiovascular Diabetology|2011|257